ArticleResearch square2026
Brain connectivity fingerprinting as a predictive biomarker of art therapy outcomes in Parkinson's disease.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Art therapy has emerged as a complementary approach to Parkinson's Disease (PD), as it engages motor, cognitive, and emotional functions. However, individual responses to art therapy are highly variable and predictors of therapeutic efficacy are largely unknown. We hypothesized that the response heterogeneity may be related to individual patterns of brain activity and connectivity. Here, we combine functional connectomics, brain fingerprinting, and machine learning to identify such patterns and predict art therapy outcomes in PD. We mapped functional connectomes from high-resolution functional MRI of 23 patients with PD collected before a six-week art therapy protocol. We also assessed individual connectome fingerprints, examined their spatial specificity, and conducted meta-analytic functional decoding to link network topography with functional domains. Leveraging these network fingerprints, we computed topological measures and developed predictive models to identify patients most likely to benefit from art therapy, reaching an accuracy of 0.83 and a ROC-AUC of 0.80. Our results demonstrate that brain fingerprint-informed network measures can capture interindividual variability of therapy response, offering a data-driven, personalized approach to treatment. This study provides the first evidence that functional connectome fingerprints can guide personalized treatments in PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.